Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 68.1	$ 75.7
Trade and other accounts receivable (less allowances of $3.8 million and $3.8 million respectively)	296.3	292.0
Inventories (less allowances of $14.7 million and $14.5 million respectively):
Finished goods	171.8	173.9
Raw materials	74.2	70.7
Total inventories	246.0	244.6
Prepaid expenses	11.6	14.7
Prepaid income taxes	4.7	2.5
Other current assets	0.0	0.8
Total current assets	626.7	630.3
Net property, plant and equipment	197.8	198.7
Operating lease right-of-use assets	31.7	32.4
Goodwill	361.2	363.0
Other intangible assets	107.1	113.5
Deferred tax assets	8.8	9.1
Pension asset	117.3	115.9
Other non-current assets	4.7	5.9
Total assets	1,455.3	1,468.8
Current liabilities:
Accounts payable	108.4	122.0
Accrued liabilities	127.9	154.0
Current portion of finance leases	0.8	1.0
Current portion of plant closure provisions	5.6	5.6
Current portion of accrued income taxes	12.3	10.3
Current portion of operating lease liabilities	11.1	10.6
Total current liabilities	266.1	303.5
Long-term debt	58.7	58.6
Finance leases, net of current portion	0.4	0.5
Plant closure provisions, net of current portion	43.7	43.7
Accrued income taxes, net of current portion	36.2	36.2
Unrecognized tax benefits	16.4	16.4
Operating lease liabilities, net of current portion	20.7	21.9
Deferred tax liabilities	49.9	49.6
Pension liabilities and post-employment benefits	17.4	17.8
Other non-current liabilities	1.5	1.7
Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	0.3	0.3
Additional paid-in capital	331.2	330.4
Treasury stock (4,993,670 and 5,047,278 shares at cost, respectively)	(94.0)	(93.3)
Retained earnings	788.6	755.5
Accumulated other comprehensive loss	(82.3)	(74.4)
Total Innospec stockholders' equity	943.8	918.5
Non-controlling interest	0.5	0.4
Total equity	944.3	918.9
Total liabilities and equity	$ 1,455.3	$ 1,468.8